Document Detail

Use of antidepressants and the risk of breast cancer: a meta-analysis.
MedLine Citation:
PMID:  23139055     Owner:  NLM     Status:  Publisher    
The goal of this study was to perform a meta-analysis to examine the association between the use of antidepressants (AD) and the risk of breast cancer. We searched the EMBASE and MEDLINE databases from inception through February 25, 2012, using search terms related to ADs and breast cancer. Two evaluators independently reviewed and selected articles and extracted data based on predetermined selection criteria. Pooled effect estimates were obtained by using random- and fixed effects meta-analyses. Of the 3,209 titles identified, 18 articles met the inclusion criteria. The overall risk of breast cancer did not increase among AD users [adjusted odds ratio (aOR) 1.02; 95 % CI 0.96-1.08]. Those who took tricyclic antidepressants (TCAs) or selective serotonin reuptake inhibitors (SSRIs) were not at increased risks of breast cancer. In subgroup meta-analyses, null associations were consistent across the type of AD, funding sources, the number of adjusted variables, medication dose, the ascertainment of exposure, and methodological quality. In subgroup analyses based on exposure duration, a marginal association was observed for the use of SSRIs < 1-2 years (aOR 1.10; 95 % CI 1.02-1.19). However, this effect was attenuated over time and those using SSRIs for more than 1-2 years had no elevated breast cancer risk. These results support the lack of a clinically meaningful association between AD use and the development of breast cancer and provide considerable reassurance. Given that the data collected to date do not support changing the current prescribing patterns for ADs, the important benefits of AD therapy must be considered.
Chun-Sick Eom; Sang Min Park; Kyung-Hwan Cho
Related Documents :
23227345 - Age at diagnosis and breast cancer survival in iran.
23671515 - Clinical and pathological variables that predict changes in tumour grade after radical ...
23103235 - 25 year disease free survival rate after irradiation of prostate cancer calculated with...
24204725 - Lack of an association between passive smoking and incidence of female breast cancer in...
12104055 - Osteonectin-expressing cells in human stomach cancer and their possible clinical signif...
24785255 - Targeted bikdd expression kills androgen-dependent and castration-resistant prostate ca...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-11-9
Journal Detail:
Title:  Breast cancer research and treatment     Volume:  -     ISSN:  1573-7217     ISO Abbreviation:  Breast Cancer Res. Treat.     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-9     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8111104     Medline TA:  Breast Cancer Res Treat     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Family Medicine, Hallym University Chuncheon Sacred Heart Hospital, Chuncheon, South Korea,
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Gender-specific elimination of continuous-infusional 5-fluorouracil in patients with gastrointestina...
Next Document:  Patterns and predictors of breast cancer chemotherapy use in Kaiser Permanente Northern California, ...